Nectar Lifesciences Q1 Results

  • BSE: 532649
  • NSE: NECLIFE
  • ISIN: INE023H01027
  • Sector: Biotechnology & Drugs
BSE
33.32-0.68 (-2.00%)
Volume27.31 K
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
32.95-0.64 (-1.91%)
Volume7.24 L
Updated: Mon 25 Nov, 2024 | 15:15:07
Today: 33.32
33.32
52-Wk: 25.02
56.39

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Nectar Lifesciences Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 359.30387.89-%394.12-%
    Selling/ General/ Admin Expenses Total 23.9920.31-%18.80-%
    Depreciation/ Amortization 15.4614.85-%15.33-%
    Other Operating Expenses Total 58.1759.80-%60.62-%
    Total Operating Expense 334.96385.59-%373.91-%
    Operating Income 24.342.30-%20.21-%
    Net Income Before Taxes 4.921.50-%3.06-%
    Net Income 2.973.68-%1.82-%
    Diluted Normalized EPS 0.130.16-%0.08-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts